BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35896684)

  • 1. The maximum length of T2-dark intraplacental bands may help predict intraoperative haemorrhage in pregnant women with placenta accreta spectrum (PAS).
    Wu X; Zhou R; Lin M; Li Y; Ying W; Li L; Ji W; Zheng K
    Abdom Radiol (NY); 2022 Oct; 47(10):3594-3603. PubMed ID: 35896684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraplacental Fetal Vessel Diameter May Help Predict for Placental Invasiveness in Pregnant Women at High Risk for Placenta Accreta Spectrum Disorders.
    Bourgioti C; Konstantinidou AE; Zafeiropoulou K; Antoniou A; Fotopoulos S; Theodora M; Daskalakis G; Nikolaidou ME; Tzavara C; Letsika A; Martzoukos EA; Moulopoulos LA
    Radiology; 2021 Feb; 298(2):403-412. PubMed ID: 33231529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of MRI-based scoring models for predicting placental invasiveness in high-risk women for placenta accreta spectrum.
    Liu Q; Zhou W; Yan Z; Li D; Lou T; Yuan Y; Rong P; Feng Z
    Eur Radiol; 2024 Feb; 34(2):957-969. PubMed ID: 37589907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraplacental T2-hypointense bands may help predict placental invasion depth and postpartum hemorrhage in placenta accrete spectrum disorders in high-risk gravid patients.
    Hu Y; Wang Y; Weng Q; Wu X; Xia S; Wang H; Cheng X; Mao C; Li X; Zhou Z; Chen C; Xu M; Wang Z; Ji J
    Magn Reson Imaging; 2022 Dec; 94():73-79. PubMed ID: 36116713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of super resolution reconstruction MRI for surgical planning in Placenta accreta spectrum disorder: Case series.
    Mufti N; Chappell J; O'Brien P; Attilakos G; Irzan H; Sokolska M; Narayanan P; Gaunt T; Humphries PD; Patel P; Whitby E; Jauniaux E; Hutchinson JC; Sebire NJ; Atkinson D; Kendall G; Ourselin S; Vercauteren T; David AL; Melbourne A
    Placenta; 2023 Oct; 142():36-45. PubMed ID: 37634372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel MRI-based diagnostic model for predicting placenta accreta spectrum.
    Xia J; Hu Y; Huang Z; Chen S; Huang L; Ruan Q; Zhao C; Deng S; Wang M; Zhang Y
    Magn Reson Imaging; 2024 Jun; 109():34-41. PubMed ID: 38408691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders.
    Bourgioti C; Zafeiropoulou K; Fotopoulos S; Nikolaidou ME; Theodora M; Daskalakis G; Tzavara C; Chatoupis K; Panourgias E; Antoniou A; Konstantinidou A; Moulopoulos LA
    J Magn Reson Imaging; 2019 Aug; 50(2):602-618. PubMed ID: 30578609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Magnetic Resonance Imaging of the Lower Uterine Segment in Pregnant Women with Central Placenta Previa with and without Placenta Accreta Spectrum from a Single Center.
    Hou S; Song Y; Wu J; Zhou L; Kang S; Chen X; Zhang L; Lu Y; Yue Y
    Med Sci Monit; 2021 Oct; 27():e932759. PubMed ID: 34675167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders.
    Cavalli C; Maggi C; Gambarini S; Fichera A; Santoro A; Grazioli L; Prefumo F; Odicino FE; Fratelli N
    J Perinat Med; 2022 Mar; 50(3):277-285. PubMed ID: 34854274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.
    Romeo V; Verde F; Sarno L; Migliorini S; Petretta M; Mainenti PP; D'Armiento M; Guida M; Brunetti A; Maurea S
    Radiol Med; 2021 Sep; 126(9):1216-1225. PubMed ID: 34156592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of placenta accreta spectrum in patients with placenta previa using a clinical, US and MRI combined model: A retrospective study with external validation.
    Maurea S; Verde F; Romeo V; Stanzione A; Mainenti PP; Raia G; Barbuto L; Iacobellis F; Santangelo F; Sarno L; Migliorini S; Petretta M; D'Armiento M; De Dominicis G; Santangelo C; Guida M; Romano L; Brunetti A
    Eur J Radiol; 2023 Nov; 168():111116. PubMed ID: 37801998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of postpartum haemorrhage for placenta accreta: Is measurement of myometrium thickness and dark intraplacental bands using MRI helpful?
    Chen X; Ming Y; Xu H; Xin Y; Yang L; Liu Z; Han Y; Huang Z; Liu Q; Zhang J
    BMC Med Imaging; 2022 Oct; 22(1):179. PubMed ID: 36253716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Placenta Accreta Spectrum Disorders in a Cohort of Pregnant Patients in the North-East Region of Romania-Diagnostic Accuracy of Ultrasound and Magnetic Resonance Imaging.
    Haba RM; Pristavu AI; Cobzeanu ML; Carauleanu A; Sadiye Scripcariu I; Vasilache IA; Minciuna DA; Negru D; Socolov DG
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
    Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome.
    Delli Pizzi A; Tavoletta A; Narciso R; Mastrodicasa D; Trebeschi S; Celentano C; Mastracchio J; Cianci R; Seccia B; Marrone L; Liberati M; Cotroneo AR; Caulo M; Basilico R
    Abdom Radiol (NY); 2019 May; 44(5):1873-1882. PubMed ID: 30600374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders.
    Jha P; Pōder L; Bourgioti C; Bharwani N; Lewis S; Kamath A; Nougaret S; Soyer P; Weston M; Castillo RP; Kido A; Forstner R; Masselli G
    Eur Radiol; 2020 May; 30(5):2604-2615. PubMed ID: 32040730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of magnetic resonance imaging in assessing placental adhesion disorder in patients with placenta previa: Correlation with histological findings.
    Maurea S; Romeo V; Mainenti PP; Ginocchio MI; Frauenfelder G; Verde F; Liuzzi R; D'Armiento M; Sarno L; Morlando M; Petretta M; Martinelli P; Brunetti A
    Eur J Radiol; 2018 Sep; 106():77-84. PubMed ID: 30150055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percreta score to differentiate between placenta accreta and placenta percreta with ultrasound and MR imaging.
    Pain FA; Dohan A; Grange G; Marcellin L; Uzan-Augui J; Goffinet F; Soyer P; Tsatsaris V
    Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1135-1145. PubMed ID: 35822244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta.
    Riteau AS; Tassin M; Chambon G; Le Vaillant C; de Laveaucoupet J; Quéré MP; Joubert M; Prevot S; Philippe HJ; Benachi A
    PLoS One; 2014; 9(4):e94866. PubMed ID: 24733409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.